Vaccine reimbursement: helping you prepare for success

This collection of case studies and considerations for conducting health economic evaluation of vaccines brings together guidancea from the National Immunization Technical Advisory Groups (NITAG) and insights from our market access work with leading vaccine manufacturers.

Find out:

  • How analysis of local NITAG/HTA requirements can help to tailor your GVD to meet local market needs
  • How gaining an understanding of the vaccine policy environment can aid strategic planning
  • Which analyses are recommended for economic analysis of vaccines in most countries.

Market access case studies include:

  • Development of a vaccine GVD template designed to meet NITAG/HTA requirements.
  • Exploring the unmet need and treatment position for vaccine assets.
  • Research to identify modeling needs of major global stakeholders for vaccines.

If you have any questions or would like to discuss current market access strategies for your vaccine assets, please do get in touch.

aCollated June 2021.

FREE EBOOK

Vaccine reimbursement: helping you prepare for success

Free download

Latest insights

PM Society Digital Awards finalist announced: the ...

Writing a great GVD that balances a ...

10 considerations for conducting health economic evaluations of ...